Niperotidine
From Wikipedia, the free encyclopedia
Names | |
---|---|
IUPAC name
(Z)-1-N'-(1,3-benzodioxol-5-ylmethyl)-1-N-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-2-nitroethene-1,1-diamine
|
|
Identifiers | |
84845-75-0 | |
3D model (Jmol) | Interactive image |
ChEMBL | ChEMBL1909284 |
ChemSpider | 11644617 |
ECHA InfoCard | 100.076.612 |
EC Number | 284-304-0 |
KEGG | D07072 |
MeSH | C073716 |
PubChem | 3033952 |
UNII | 12JBD7U72K |
|
|
|
|
Properties | |
C20H26N4O5S | |
Molar mass | 434.50924 g/mol |
Pharmacology | |
A02BA05 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
verify (what is ?) | |
Infobox references | |
Niperotidine is a histamine antagonist selective for the H2 subtype. It was trialled as a treatment for excessive gastric acidity,[1] but withdrawn after human trials showed liver damage.[2]
References[edit]
- ^ Palasciano G, Maggi V, Portincasa P. The effect of the H2-antagonist niperotidine on intragastric acidity in healthy subjects undergoing 24-hour pH-monitoring. Italian Journal of Gastroenterology. 1990 Oct;22(5):291-4. PMID 1983712
- ^ Gasbarrini G, Gentiloni N, Febbraro S, Gasbarrini A, Di Campli C, Cesana M, Miglio F, Miglioli M, Ghinelli F, D'Ambrosi A, Amoroso P, Pacini F, Salvadori G. Acute liver injury related to the use of niperotidine. Journal of Hepatology. 1997 Sep;27(3):583-6. PMID 9314138
This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |